🏥 El #HospiLaPaz revalida su liderazgo en España en reputación sanitaria, según @mercoranking
🥇 Cuenta con 16 servicios en el 1º puesto.
🥈 Nueve servicios en la 2ª posición.
🥉 Y nueve siendo 3º en la clasificación.
¡Enhorabuena!
#SomosLaPaz
🔗https://t.co/TN81sbu9cp
The synergy between Hospital La Paz’s Elekta Unity MR-Linac and @PhilipsHealth's Ambition MR-RT provides high-quality MR imaging and seamless MR-only workflows. Read how the workflow is key to personalized, efficient radiotherapy ➡️ https://t.co/E92csdPBMU
🏥 El #Hospital12deOctubre incorpora la radioablación cardiaca para tratar taquicardias ventriculares.
👨🏻🔬 Radiofísica, Cardiología y Oncología Radioterápica han tratado con éxito a seis pacientes con esta técnica.
🔗 + info: https://t.co/sfbuRmzGyT
#somosdel12
Just out on @TheLancetOncol
The Phase3 SENOMAC🇸🇪Trial in #BreastCancer
Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial
In luminal breast cancer, while completion axillary lymph node dissection (cALND) can reveal the presence of four or more nodal metastases—a key criterion for adjuvant abemaciclib treatment—it also poses a significant risk of severe arm morbidity.
The SENOMAC trial compared cALND to sentinel lymph node biopsy alone in patients with early-stage, node-positive breast cancer.
➡️Findings showed that cALND led to severe impairment in physical arm function in a notable percentage of patients, suggesting that its use should be discouraged when the sole purpose is to determine eligibility for adjuvant abemaciclib, given the high morbidity risk relative to the potential benefit.
https://t.co/jZ9Rp7XA8x
@Sara_Alkner@OlofssonBagge@MalinASund
#OncoAlertAF
@nataliagandur@acampsmalea@MartaPerachino@heinrich_kat @BiagioRicciutMD @DenizCanGuven1@yekeduz_emre@HHorinouchi@FadiHaddad_MD@Dr_Ivanoncologo@Abdallah81MD@FernandoOnco@ElisaAgostinett@dr_yakupergun@to_be_elizabeth@anmwongNZ@lungoncdoc@ADesaiMD@bavilima@realbowtiedoc
Las Dragonas🐉 del equipo BCS🚣♀️Sevilla nos dieron esta semana una lección de vida. Mujeres♀️que han pasado o están en proceso de afrontar cáncer de mama unidas por el deporte para una superación del cáncer en equipo💪
#PALADASDEVIDA
https://t.co/1Yh005Tqak
ESTRO Guideline on Prostate Bed Delineation for Postoperative Radiotherapy in #Prostate#Cancer, just published in @ctRO_journal and presented this morning at #ESTRO23.
Access the article 👉 https://t.co/o7hZLD2ZpQ
🆕Does PSA at time of salvage therapy after radical prostatectomy for prostate cancer matter? Tilki, D'Amico, and co-authors report multinational findings here: https://t.co/eW2WMbvGP7
Incorporating Prostate-specific Membrane Antigen Positron Emission Tomography in Management Decisions for Men with Newly Diagnosed or Biochemically Recurrent #ProstateCancer https://t.co/IPzcruoWYf #MedTwitter#CancerResearch#MolecularImaging
Radiotherapy 🏥is an often poorly understood #cancer treatment.
But it is an essential, life saving treatment that >50% of all people will cancer 🦀 will benefit from.
Here's how you can advocate for your loved ones in 4 easy steps: a thread🧵
#radonc
1/692